Sofosbuvir Synthesis via Resin-Supported Lipase Mono-Deacetylation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for synthesizing Sofosbuvir are hindered by non-selective Grignard reactions, leading to insoluble double salts and the formation of difficult-to-separate by-products, requiring lengthy purification processes to achieve regulatory compliance.
Innovation Solution
A selective mono-deacetylation reaction using resin-supported lipase from Candida Antarctica in a polar protic solvent, followed by specific base and solvent conditions, to produce Sofosbuvir with high yield and purity, avoiding the formation of isomer and di-substituted by-products.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If Grignard reagent is used for salification of nucleosidic intermediates, then the reaction proceeds, but non-selective reaction occurs forming insoluble double salts and by-products requiring lengthy purification
Solution Approach 1:
The patent changes the chemical parameters of the reaction system by introducing a chiral catalyst (resin-supported lipase from Candida Antarctica) and controlling stoichiometric ratios (1:1.05 to 1:1.5 of acid chloride to nucleoside intermediate). This transforms the non-selective Grignard reaction into a selective enzymatic reaction that forms only the desired mono-salt, eliminating double salts and by-products while maintaining high reaction efficiency.
2Ease of manufacture
If non-selective Grignard salification is used, then the reaction is straightforward, but double salts and by-products are formed making purification difficult
Solution Approach 1:
The patent extracts and removes the harmful elements (double salts and by-products) from the reaction system by using selective enzymatic catalysis that only forms the desired mono-salt. The resin-supported lipase catalyst specifically catalyzes the formation of the mono-salt while leaving other potential products unaffected, thereby eliminating the need for complex purification steps to remove multiple by-products.
Solution Approach 2:
The patent introduces a resin-supported lipase catalyst as an intermediary that mediates the salification reaction. This catalyst provides chiral recognition and selectivity, allowing the reaction to proceed through a controlled mechanism that forms only the desired mono-salt. The intermediary catalyst enables the transformation to occur under mild conditions with high specificity, avoiding the formation of problematic double salts and by-products.
3Reliability
If conventional salification methods are used, then the process is established, but regulatory compliance requires lengthy purification to achieve sufficient purity
Solution Approach 1:
The patent performs preliminary selective salification using resin-supported lipase catalysis to ensure that only the desired mono-salt is formed in the first place. By preventing the formation of double salts and by-products at the source through chiral catalytic control, the process eliminates the need for extensive subsequent purification steps, thereby achieving regulatory compliance faster and more efficiently.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves high purity and yield of Sofosbuvir, simplifying purification and reducing the complexity of manufacturing, thereby overcoming the drawbacks of previous methods.
Implementation Method 1
The selective mono-deacetylation reaction of the process object of the present invention can be carried out enzymatically using a resin supported lipase, preferably deriving from Candida Antarctica
Implementation Method 2
The selective mono-deacetylation reaction of a compound of formula (V) to obtain a compound of formula (IV)
Data Source
AI summary
The present invention relates to a process for the synthesis of Sofosbuvir of formula (I) comprising the selective mono-deacetylation reaction of a compound of formula (V) to obtain a compound of formula (IV).